Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Clinical Trials on High Grade Glioma (HGG) of the Brain With BRAF Aberration in Taiwan
Total 0 results
Nothing found
Sponsors and Collaborators
Ana Paula Costella
Fundación Pública Andaluza Progreso y Salud
Pharmaspecific
Gulsah Ilhan
Affiliated Hospital of Yunnan University of Traditional Chinese Medicine
King Baudouin Foundation
IRCCS Don Gnocchi, Milano, Italy
Korrus Inc.
Center for Rare Neurological Diseases, Norcross, GA
Army Hospital, Percy
Prof. Abdel-Megeeed I. Abdel- Megeeed
Michael J. Wesley, PhD
Manmohan Cardiothoracic Vascular and Transplant Center
Edanz Group Japan Ltd
Laboratorios Viñas, S.A.
Ruba Musharbash Nutrition Consultancy Center
Centre of Malariology Parasitology and Entomology, Department of Communicable Diseases Control, Ministry of Health, Lao PDR
Frankel, Amylynne, M.D.
HeartPoint Global
Walgreens Co.
View Full List
Medical Conditions
Lung Neuroendocrine Tumor
Uncontrolled Type 2 Diabetes Mellitus
Impairment, Coordination
Localized Unresectable Adult Primary Liver Cancer
Ankylosed Teeth
Ann Arbor Stage IVB Hodgkin Lymphoma
Malignant Intracranial Germ Cell Tumor
Developmental Language Disorder and Language Impairment
Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery Requiring Extracorporeal Circulation
Paralysis of Vocal Cords or Larynx
Facial Involvement
Severe Atopic Dermatitis
Coagulation Disorder Neonatal
Gastroenteritis Rotavirus
Menopause
Kidney Damage
Cognitive Function, Social 1
Brain Arteriovenous Malformation
Pelvis Tumors
Cardiovascular Outcomes
View Full List
Drug Interventions
Ozanimod
Tocilizumab 20 MG/ML Intravenous Solution [ACTEMRA]
Apremilast
Camrelizumab for injection (200 mg, iv), D1, Q2W, 14-day cycle
Methotrexate
Transdermal estradiol
Dexmedetomidine
Miglustat
FHND5071
Insulin
Interleukin-2
Exendin 9-39
Extended release guanfacine
CD25 treatment
5-Fluorouracil
Interferon beta-1b (Betaferon, BAY86-5046)
Rituximab plus CHOP
Lidocaine/ ketamine
LDEPA
Thiotepa
View Full List
CROs by country
Contract Research Organizations in Angola
Contract Research Organizations in Congo, DR of
Contract Research Organizations in Djibouti
Contract Research Organizations in Gabon
Contract Research Organizations in Ireland
Contract Research Organizations in Mauritius
Contract Research Organizations in Morocco
Contract Research Organizations in Paraguay
Contract Research Organizations in Philippines
Contract Research Organizations in Romania
Contract Research Organizations in Saudi Arabia
Contract Research Organizations in South Korea
Contract Research Organizations in Uzbekistan
CRO list by country
CROs in Austria
Eppendorf
Innovacell Biotechnologie
ABF Pharmaceutical Services
Envigo
The Siesta Group
BBMRI-ERIC
Globopharm
Evercyte
Medical University of Innsbruck
IONICON
All CROs in Austria
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe